Edward Kowlowitz, MD, leading authority on chronic neuropathic pain, international leader in spinal cord stimulation therapy and founder of the Center for Pain Management in Indianapolis, recently implanted the industry’s newest spinal cord stimulator, Protégé™ IPG, produced by St. Jude Medical, in a local patient just six days after the innovative medical device received FDA approval – making him the first doctor in Indiana to implant the new high tech spinal cord stimulator. Since 1992, the practice has treated more than 50,000 Hoosiers for pain and implants 120 spinal cord stimulators and consistently offers its patients immediate access to the market’s newest medical advances in chronic pain treatment.
“As chronic pain specialists, it is our responsibility to stay on the cutting edge of medical breakthroughs that could offer our patients relief from debilitating pain and result in a better quality of life,” said Dr. Kowlowitz, who recently implanted St. Jude Medical’s Protégé™ IPG neurostimulator in a local Indianapolis patient just days after the new medical device received FDA approval. “For the last 20 years, we’ve been able to offer our patients immediate access to the newest medical devices, procedures and technologies by proving ourselves as a trusted and experienced physician team in spinal cord stimulator therapy and chronic pain management. In addition to St. Jude Medical, we also work closely with neurostimulation innovators such as Medtronic and Boston Scientific, so our patients receive the newest medical advances as soon as they are available.”
Edward Kowlowitz, MD is a board certified anesthesiologist and the founder and medical director of the Center for Pain Management on the northside of Indianapolis. During his distinguished career, he has personally conducted extensive research and training with advanced neuromodulation systems and performed and consulted on thousands of SCS surgical procedures.
Chronic pain is a largely under-treated and misunderstood disease. According to the American Academy of Pain Medicine, chronic pain affects 100 million Americans, more than heart disease, cancer and diabetes combined. The Institute of Medicine reports that workplace pain costs businesses $297 – $335 billion in lost productivity annually (based on days of work missed, hours of work lost and lower wages). This does not take into account medical or other associated costs.
Spinal cord stimulators (SCS) have been used effectively for 40 years to treat chronic pain. Similar in function and appearance to a cardiac pacemaker, neurostimulators deliver mild electrical pulses to the spinal cord, which interrupt or mask the pain signals’ transmission to the brain. Studies show SCS reduce pain symptoms by 50% or more (Source: SPINE Magazine), offering patients significant relief from pain, greater functionality, higher activity levels and a better overall quality of life. According to a new report from BCC Research, the chronic pain medical device market is expected to reach to grow by 1.8% to $2.8 billion in 2018 – the fastest growing segment of the global neurostimulation device category.
Indianapolis’ Center for Pain Management was founded in 1992 by Dr. Edward Kowlowitz, M.D., a board-certified anesthesiologist with specialized qualifications in chronic pain and acute pain management. The medical clinic offers comprehensive diagnostic services, pain management treatments and surgical procedures. The Center’s medical staff consists of board-certified, pain-specialty physicians and a team of clinicians who specialize in comprehensive diagnostic and multidisciplinary treatment modalities that include pain interventional procedures, physical therapy, pain medication management, spinal cord stimulation implants and psychological counseling for pain. The medical practice also has an on-site surgery center and radiology/MRI services. For more information, call 317-706-PAIN or visit www.IndyPain.com.